Chronic myeloid leukemia (CML) is a type of Philadelphia chromosome-positive (Ph+) leukemia affecting hematopoietic stem cells. Treatment and management of CML focus on improving the survival rate and quality of a patient’s life. The improvement can be brought about with the help of advance therapeutic approaches, early diagnosis, and targeted drug therapy. Take this survey to share your opinion about the treatment and management of CML. Chronic myeloid leukemia (CML) is a malignancy of hematopoietic cells, namely, myeloid cells found in the bone marrow.
Targeted therapy is considered a gold standard for the treatment of CML patients. The targeted therapy includes the use of tyrosine kinase inhibitors (TKIs). The development of TKIs has significantly improved the overall prognosis of CML. This survey is being conducted to know your opinion on the treatment options while managing CML.…
